Symphony Environmental Technologies PLC (AIM: SYM) CEO Michael Laurier joined Steve Darling from Proactive with news the company has received U.S. Food & Drugs Administration approval or its d2p antimicrobial technology.
Laurier discusses what that means for the company and what their next steps are including what markets they plan on moving into.
Price: 26 GBX
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Symphony Environmental Technologies PLC named herein, including the promotion by the Company of Symphony Environmental Technologies PLC in any...
FOR OUR FULL DISCLAIMER CLICK HERE
Ian Bristow, Finance Director of Symphony Environmental Technologies (LON:SYM) tells Proactive how after the October announcement that profits would be not less than £350,000, Symphony has now raised guidance to "not less than £400,000", up from £123,000 in 2016. The global specialist in...
Health
Retail & consumer
Health
Health
